 |
2-[4-Methoxy-3-(2-m-tolyl-ethoxy)-benzoylamino]-indian-2-carboxylic acid |
|---|---|
| Trade Name | |
| Orphan Indication | Systemic scleroderma |
| USA Market Approval | USA |
| USA Designation Date | 2013-05-14 00:00:00 |
| Sponsor | Sanofi U. S., Inc.;55 Corporate Drive;Bridgewater, New Jersey, 08807 |
